Qiu, W. Et Al. 2011. Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Oncotarget , vol.2, no.11 , 862-873.

Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C., ... Chen, D.(2011). Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Oncotarget , vol.2, no.11, 862-873.

Qiu, Wanglong Et Al. "Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo," Oncotarget , vol.2, no.11, 862-873, 2011

Qiu, Wanglong Et Al. "Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo." Oncotarget , vol.2, no.11, pp.862-873, 2011

Qiu, W. Et Al. (2011) . "Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo." Oncotarget , vol.2, no.11, pp.862-873.

@article{article, author={Wanglong Qiu Et Al. }, title={Disruption of p16 and activation of kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo}, journal={Oncotarget}, year=2011, pages={862-873} }